{"id":448974,"title":"Guidance Document: Part C, Division 5 of the Food and Drug Regulations “Drugs for Clinical Trials Involving Human Subjects” (GUI-0100) - Summary - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T18:08:31.714000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-clinical-practices/guidance-documents/guidance-drugs-clinical-trials-human-subjects-gui-0100.html?wbdisable=false","snippet":"Guidance Document: Part C, Division 5 of the Food and Drug Regulations “Drugs for Clinical Trials Involving Human Subjects” (GUI-0100) - Summary File a Clinical Trial Application ( CTA ) File a Clinical Trial Application Amendment ( CTA-A ) Report Adverse Drug Reactions ( ADR s)…","rawSnapshotUrl":"/api/snapshots/raw/448974","browseUrl":"https://replay.healtharchive.ca/job-6/20260103180831/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-clinical-practices/guidance-documents/guidance-drugs-clinical-trials-human-subjects-gui-0100.html?wbdisable=false#ha_snapshot=448974","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}